openPR Logo
Press release

Neuropathic Pain Market: How the Market has witnessed Substantial Growth in recent years?

10-20-2021 11:14 AM CET | Health & Medicine

Press release from: StraitsResearch

Neuropathic Pain Market

Neuropathic Pain Market

Neuropathic Pain Market Snapshot:

The global neuropathic pain market was valued at USD 2,052.9 million in 2018 and is expected to rise at a CAGR of 5.3% during the forecast period.

Neuropathic pain is caused when a disease damages the somatosensory nervous system.  People suffering from diabetes, vascular and blood problems, and kidney and liver disorders are highly prone to develop neuropathic pain. In addition, a high rate of ‘fall injuries’ can cause neurological diseases.  For instance, it was estimated that over 3 million geriatric people were treated in emergency departments, and 800,000 patients were hospitalized for fall injuries in the U.S. As per International Association of the pain,  around 7–8% of adults were registered to have neuropathic pain in 2015. Similarly, in the U. K., 26% diabetic people were found to have peripheral neuropathic pain worldwide.
Americas is housing huge population suffering from a variety of neurological issues such as stroke, Parkinson’s disease, brain cancer, epilepsy, brain injury, dementia, prion disease, Huntington’s disease, multiple sclerosis, and a host of neuromuscular conditions. For Instance, In U.S., around 235,000 cases of traumatic brain injuries are reported every year, which is in excess of 20 times the number of hospitalizations for spinal cord injury. Similarly, around 2.4% of the U.S. population suffered from peripheral neuropathy in 2015. As per National Institutes of Health estimation, around 165,813 people are currently living with brain and other nervous system disorders in the U.S. In the Americas, the prevalence of neuropathic disorders is increasing at an alarming rate. To curb the prevalence,  various organizations and pharmaceutical industries are focusing on the development of advanced treatment for neuropathic pain. As per the University of Maryland Medical Centers, in 2018, developed ultrasound treatment for neuropathic pain. In addition, FDA approved Lyrica for the management of neuropathic pain associated with diabetic peripheral neuropathy.

Most of neurological patient prefer neurological specialist for the neurological disorders is major factor for the market growth. Presence of adoption advanced technology such as neuro-radiology services, neuro-intensive care facilities and medical and radiation oncology services is expected to boost the market growth. For instance, In U.K.186,000 patients were treated at the National Hospital every year, Similarly over. 9,000 neurosurgical operations, 40,000 CT-Scan and MRI scans are performed each year in the U.K.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/neuropathic-pain-market/request-sample

The Major Prominent Players Covered in this Report:
Pfizer Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb and Company, Eli Lily and Company, GlaxoSmithKline PLC, Sanofi S.A., Biogen Idec Inc., Baxter Healthcare Corporation, and Depomed Inc. & More.

By Type, Peripheral Neuropathy,Entrapment Neuropathy,Post Traumatic Neuropathy,Phantom Limb Pain,Post Herpetic Neuralgia (PHN),Trigeminal Neuralgia,Others
By Diagnosis and Treatment,Imaging, blood tests, physical examination, Medication, Multimodal therapy, OthersDistribution Channel, Online Pharmacies, Retail Pharmacies, Drug Stores, Others
By End-User, Hospitals, Clinics, Research Organizations, Others

The report is a valued asset for the active players, new participants, and future investors, and provides a comprehensive assessment across regions such as:

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Neuropathic Pain in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Neuropathic Pain market during the forecast period 2019-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Neuropathic Pain and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Neuropathic Pain. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/neuropathic-pain-market/toc

Key Questions Answered in The Report:
What will the Neuropathic Pain market growth rate?
What are the key factors driving the global Neuropathic Pain market?
Who are the key manufacturers in the Neuropathic Pain market space?
What are the market opportunities, market risk, and market overview of the Neuropathic Pain market?
What are sales, revenue, and price analysis of top manufacturers of the Neuropathic Pain market?
Who are the distributors, traders, and dealers of the Neuropathic Pain market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Neuropathic Pain Industry?
What are sales, revenue, and price analysis by regions of Neuropathic Pain industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Our Report Covers:
Historical inferences, findings & analysis of the market from 2016 to 2018
Projections and performance forecast analysis for the future from 2019 to 2026
Production and consumption point of view (POV) analysis
Market drivers, restraint and opportunity analysis, to define market dynamics covering industry, regulatory, innovation, technological & pricing trends
Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability, and prospects.

Key Neuropathic Pain Market Trends:
- The report identifies, determines, and forecasts the Global Neuropathic Pain Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Neuropathic Pain Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Neuropathic Pain Market.

Browse Full Report @ 
https://straitsresearch.com/report/neuropathic-pain-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/neuropathic-pain-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market: How the Market has witnessed Substantial Growth in recent years? here

News-ID: 2434433 • Views: 298

More Releases from StraitsResearch

Offshore Drilling Market Share is Estimated to Reach USD 187,141.2 Million by 20 …
Offshore Drilling Market 2021 Overview: The growth can be attributed to an increase in drilling and well-intervention activities driven by the rising energy demand across the globe. The stringent government regulations related to environmental concerns from onshore drilling activities and depleting onshore reservoirs have shifted the focus of oil exploration companies from onshore drilling activities to offshore drilling activities. Also, recent technological advancements, such as subsea processing and FLNG technology are
Eye Health Supplements Market Insight Report 2021; Impressive Healthy 6.1 % CAGR …
Eye Health Supplements Market Snapshot 2021: The growing awareness about the availability of various supplements in the market that can address health concerns has helped in the market penetration of these products. Moreover, the recent corporate trends of work-from-home for a prolonged number of hours have surged the cases of eye irritations, dry eyes, eye fatigue, and myopia, further driving the market growth. The Eye Health Supplements Market Study by StraitsResearch gives a vital tool and
Know How Polyolefin Foam Market Will Grow with Higher CAGR After Covid-19 Pandem …
Polyolefin Foam Industry Outlook 2021: With the growing industrialization and globalization in many developing economies, the market is witnessing growth in the sale of automobiles and production capacity year on year. Ongoing efforts in the automobile industry to make vehicle lightweight and more energy-efficient is likely to fuel the growth of the polyolefin foams market during the forecast period. Polyolefin Foam market research report has been prepared with most up-to-date insight and
Cereal Bar Market Growth Report 2021; New Innovations in Food and Beverages Sect …
Cereal Bar Industry Outlook 2021: Global population has been witnessing a gradual decrease in terms of their mobility. Increasing automation has reduced the amount of manual labour to be put into doing any activity which has resulted in the consumers leading a more sedentary lifestyle. There have been multiple reports publishing the alarming rate at which global obesity has been increasing. Cereal Bar market research report has been prepared with most up-to-date

All 5 Releases


More Releases for Neuropathic

Neuropathic Pain Therapeutics Market: Competitive Dynamics & Global Outlook 2020 …
Global Info Research offers a latest published report on Neuropathic Pain Therapeutics Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Neuropathic Pain Therapeutics Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Neuropathic Pain Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H1 2017, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape. Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. The nerve fibres could be damaged resulting in the generation of abnormal signals. Neuropathic pain is also exhibited along with many other diseases.
Neuropathic Pain Market Estimated to Flourish by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The
Neuropathic Pain Market to Perceive Substantial Growth During 2024
According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Neuropathic Pain: Anticonvulsants Drug Class Segment Projected to Witness the Highest Growth Through 2024’, the global neuropathic pain market was valued at US$ 5.2 Bn in 2015 and is estimated to reach a market valuation of US$ 5.4 Bn by 2016. The market is projected to expand at a CAGR of 5.6% during an
Neuropathic Pain Market Stood at US$ 8.3 Bn by 2024
The global neuropathic pain market is segmented on the basis of drug class, indication, and distribution channel. On the basis of drug class, the market has been segmented into Tricyclic Antidepressant, Anticonvulsants, Local Anaesthesia, Opioids, Steroids, and Others. The Anticonvulsants drug class segment is expected to remain the largest segment in the global neuropathic pain market, registering a CAGR of 6.4% in terms of value over the forecast period. The
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also